Paper36920988
Incidence, risk factors, and clinical outcomes of HBV reactivation in non-liver solid organ transplant recipients with resolved HBV infection: A systematic review and meta-analysis.
Yin S and 4 others. PLoS Med, 2023. Cited by 15 papers, by iCite.
Cite this record
ConductScience Library. Incidence, risk factors, and clinical outcomes of HBV reactivation in non-liver solid organ transplant recipients with resolved HBV infection: A systematic review and meta-analysis. Papers, record 36920988. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36920988
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Hepatitis B | Major topic |
| Organ Transplantation | Major topic |
| Humans | |
| Hepatitis B virus | |
| Rituximab | |
| Retrospective Studies | |
| Incidence | |
| Antiviral Agents | |
| Risk Factors | |
| Hepatitis B Antibodies |
Source PubMed
References35
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 29621059 | Presence of Hepatitis B Surface Antibody in Addition to Hepatitis B Core Antibody Confers Protection Against Hepatitis B Virus Infection in Hepatitis B Surface Antigen-negative Patients Undergoing Kidney Transplantation. | Transplantation | 2018 | https://conductscience.org/library/papers/29621059 | PubMed |
| 2 | 15653420 | HBV reactivation after kidney transplantation. | J Clin Virol | 2005 | https://conductscience.org/library/papers/15653420 | PubMed |
| 3 | 25707744 | Solid organ transplantation from hepatitis B virus-positive donors: consensus guidelines for recipient management. | Am J Transplant | 2015 | https://conductscience.org/library/papers/25707744 | PubMed |
| 4 | 32057171 | Hepatitis B reactivation after kidney transplantation in hepatitis B surface antigen-negative, core antibody-positive recipients. | J Viral Hepat | 2020 | https://conductscience.org/library/papers/32057171 | PubMed |
| 5 | 25363471 | Thymoglobulin induction in heart transplantation: patient selection and implications for maintenance immunosuppression. | Transpl Int | 2015 | https://conductscience.org/library/papers/25363471 | PubMed |
| 6 | 19622551 | Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. | BMJ | 2009 | https://conductscience.org/library/papers/19622551 | PubMed |
| 7 | 19072749 | Why add anything to nothing? The arcsine difference as a measure of treatment effect in meta-analysis with zero cells. | Stat Med | 2009 | https://conductscience.org/library/papers/19072749 | PubMed |
| 8 | 20827667 | Random effects meta-analysis of event outcome in the framework of the generalized linear mixed model with applications in sparse data. | Stat Med | 2010 | https://conductscience.org/library/papers/20827667 | PubMed |
| 9 | 22436845 | EASL clinical practice guidelines: Management of chronic hepatitis B virus infection. | J Hepatol | 2012 | https://conductscience.org/library/papers/22436845 | PubMed |
| 10 | 32118794 | Anti-HBc impacts on the risk of hepatitis B reactivation but not on survival of solid-organ transplant recipients. | Medicine (Baltimore) | 2020 | https://conductscience.org/library/papers/32118794 | PubMed |
| 11 | 3802833 | Meta-analysis in clinical trials. | Control Clin Trials | 1986 | https://conductscience.org/library/papers/3802833 | PubMed |
| 12 | 32301874 | KDIGO Clinical Practice Guideline on the Evaluation and Management of Candidates for Kidney Transplantation. | Transplantation | 2020 | https://conductscience.org/library/papers/32301874 | PubMed |
| 13 | 28371939 | Rituximab and hepatitis B reactivation in HBsAg-negative/anti-HBc-positive kidney transplant recipients. | Nephrol Dial Transplant | 2017 | https://conductscience.org/library/papers/28371939 | PubMed |
| 14 | 30295412 | Risk of hepatitis B reactivation in hepatitis B surface antigen seronegative and core antibody seropositive kidney transplant recipients. | Transpl Infect Dis | 2019 | https://conductscience.org/library/papers/30295412 | PubMed |
| 15 | 28856548 | Risk of hepatitis B reactivation in HBsAg-negative/HBcAb-positive patients with undetectable serum HBV DNA after treatment with rituximab for lymphoma: a meta-analysis. | Hepatol Int | 2017 | https://conductscience.org/library/papers/28856548 | PubMed |
| 16 | 23726628 | Clinical and virologic courses of hepatitis B surface antigen-negative and hepatitis B core or hepatitis B surface antibody-positive renal transplant recipients. | Transplant Proc | 2013 | https://conductscience.org/library/papers/23726628 | PubMed |
| 17 | 25154638 | Hepatitis B virus (HBV) reverse seroconversion (RS) can be prevented even in non-responders to hepatitis B vaccine after allogeneic stem cell transplantation: long-term analysis of intervention in RS with vaccine for patients with previous HBV infection. | Transpl Infect Dis | 2014 | https://conductscience.org/library/papers/25154638 | PubMed |
| 18 | 28128861 | Role of surface antibody in hepatitis B reactivation in patients with resolved infection and hematologic malignancy: A meta-analysis. | Hepatology | 2017 | https://conductscience.org/library/papers/28128861 | PubMed |
| 19 | 22921412 | Significant rate of hepatitis B reactivation following kidney transplantation in patients with resolved infection. | J Clin Virol | 2012 | https://conductscience.org/library/papers/22921412 | PubMed |
| 20 | 34427860 | APASL clinical practice guideline on hepatitis B reactivation related to the use of immunosuppressive therapy. | Hepatol Int | 2021 | https://conductscience.org/library/papers/34427860 | PubMed |
Cited by9
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 15 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42953154 | Risk factors for postpartum alanine aminotransferase elevation in women with chronic hepatitis B infection: a systematic review and meta-analysis. | Front Public Health | 2026 | https://conductscience.org/library/papers/42953154 | PubMed |
| 42609305 | Epidemiologic and clinical characteristics of Mycobacterium tuberculosis infection in Guangxi, China, 2018-2023: a retrospective study. | Front Cell Infect Microbiol | 2026 | https://conductscience.org/library/papers/42609305 | PubMed |
| 42590149 | Long-Term Clinical Outcomes of Kidney Transplantation from Hepatitis B Surface Antigen (HBsAg)-Positive Donors to HBsAg-Negative Recipients: A Systematic Review and Meta-Analysis of Real-World Studies. | J Clin Med | 2026 | https://conductscience.org/library/papers/42590149 | PubMed |
| 42281419 | KASL clinical practice guidelines for management of chronic hepatitis B Endorsed by the East Asia Liver Alliance (EALA). | Clin Mol Hepatol | 2026 | https://conductscience.org/library/papers/42281419 | PubMed |
| 42005560 | Hepatitis B, C, and E viruses in solid organ transplantation: donor and recipient perspectives. | JHLT Open | 2026 | https://conductscience.org/library/papers/42005560 | PubMed |
| 41183666 | Antineoplastic agents-associated hepatitis B virus reactivation: Research progress and molecular mechanisms. | Virus Res | 2025 | https://conductscience.org/library/papers/41183666 | PubMed |
| 40753237 | Synchronous triple-negative breast cancer, rectal adenocarcinoma, and chemotherapy-induced hepatitis B virus reactivation: a case report and review of the literature. | J Med Case Rep | 2025 | https://conductscience.org/library/papers/40753237 | PubMed |
| 40143316 | HBV Reactivation in Immunosuppressed Patients: Screening, Prevention, and Management Including Solid Organ Transplant Recipients. | Viruses | 2025 | https://conductscience.org/library/papers/40143316 | PubMed |
| 39066442 | Hepatitis B Reactivation and Vaccination Effectiveness after Solid Organ Transplantation: A Matched Case-Control Study. | Vaccines (Basel) | 2024 | https://conductscience.org/library/papers/39066442 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| HLA-A | 3105 | PubTator's text mining | https://conductscience.org/library/genes/3105 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36920988
GET https://conductscience.org/api/papers/v1/36920988/references?page=2